Company Filing History:
Years Active: 1999-2000
Title: Ho Law - Innovator in Serotonin Receptor Binding Activity
Introduction
Ho Law is a notable inventor based in Meylan, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with serotonin receptors. With a total of 2 patents, his work focuses on addressing central nervous system (CNS) conditions.
Latest Patents
Ho Law's latest patents include innovative compounds known as benzylamidine derivatives with serotonin receptor binding activity. These inventions relate to compounds that exhibit serotonin receptor binding activity and their medical applications, especially in treating CNS conditions such as migraines. The compounds are described by a general formula that includes specific structural components, allowing for targeted therapeutic effects.
Career Highlights
Ho Law is affiliated with Virginia Commonwealth University, where he continues to advance research in pharmacology and medicinal chemistry. His work has garnered attention for its potential impact on treating various neurological disorders.
Collaborations
Ho Law collaborates with Richard A Glennon, a fellow researcher, to further explore the applications of his patented compounds in the medical field.
Conclusion
Ho Law's contributions to the field of serotonin receptor binding activity highlight his innovative spirit and dedication to improving treatments for CNS conditions. His work continues to inspire advancements in medicinal chemistry and pharmacology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.